AIDTES

Company Overview

Snapshot

Founded in April 2020 by Rian Twizer, AIDTES operated with 1–10 employees, developing software diagnostic solutions. The company ceased operations in February 2023.

Business overview

AIDTES specializes in developing and implementing advanced software solutions for the analysis, interpretation, and connectivity of clinical molecular diagnostics. The company's core technology automates high-throughput PCR tests, ensuring data security and aiming for high accuracy while reducing costs and increasing efficiency. AIDTES's software, which can be deployed on-premises or as a cloud-based solution, is customizable for various qPCR tests and thermocyclers. It serves markets across Europe, Africa, Asia, Americas, and Australia, targeting laboratories, healthcare providers, and enterprises within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is AIDTES's primary focus?

AIDTES focuses on developing and implementing novel software solutions for the analysis, interpretation, and connectivity of clinical molecular diagnostics, specifically for PCR tests.

When was AIDTES founded?

AIDTES was founded in April 2020.

What is the status of AIDTES?

AIDTES is currently non-active and ceased operations in February 2023.

Who is the founder of AIDTES?

Rian Twizer is the founder of AIDTES.

What kind of technology does AIDTES utilize?

AIDTES utilizes machine learning and artificial intelligence within its software applications, offering both on-premises and cloud-based solutions for diagnostics.